Corient Private Wealth’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
34,875
+17,619
| +102% | +$5.06M | 0.01% | 572 |
|
|
2025
Q1 | $5.32M | Sell |
17,256
-1,433
| -8% | -$442K | 0.01% | 670 |
|
|
2024
Q4 | $6.59M | Sell |
18,689
-2,041
| -10% | -$720K | 0.01% | 624 |
|
|
2024
Q3 | $7.43M | Buy |
20,730
+3,167
| +18% | +$1.13M | 0.01% | 626 |
|
|
2024
Q2 | $5.59M | Buy |
17,563
+2,776
| +19% | +$884K | 0.01% | 676 |
|
|
2024
Q1 | $3.4M | Sell |
14,787
-2,249
| -13% | -$517K | 0.01% | 811 |
|
|
2023
Q4 | $3.75M | Buy |
17,036
+461
| +3% | +$101K | 0.01% | 780 |
|
|
2023
Q3 | $3.74M | Buy |
16,575
+235
| +1% | +$53.1K | 0.01% | 708 |
|
|
2023
Q2 | $3.61M | Buy |
16,340
+8,374
| +105% | +$1.85M | 0.01% | 723 |
|
|
2023
Q1 | $1.78M | Buy |
7,966
+867
| +12% | +$194K | ﹤0.01% | 875 |
|
|
2022
Q4 | $1.97M | Buy |
+7,099
| New | +$1.97M | 0.01% | 706 |
|